362 related articles for article (PubMed ID: 9049190)
21. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
22. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
Glantz A; Marschall HU; Lammert F; Mattsson LA
Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
[TBL] [Abstract][Full Text] [Related]
23. Cross-Sectional Analysis of Progressive Familial Intrahepatic Cholestasis in Puerto Rican Children.
Soler DM; Del Valle AI; Fernandez-Lube D; Shneider BL
P R Health Sci J; 2016 Dec; 35(4):220-223. PubMed ID: 27898169
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis.
Socha P; Nowicka G; Jankowska I; Rujner J; Pawłowska J; Socha J
Dig Dis Sci; 2000 Apr; 45(4):675-9. PubMed ID: 10759233
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
Berkane N; Cocheton JJ; Brehier D; Merviel P; Wolf C; Lefèvre G; Uzan S
Acta Obstet Gynecol Scand; 2000 Nov; 79(11):941-6. PubMed ID: 11081677
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid treatment in children with Byler disease.
Dinler G; Koçak N; Ozen H; Yüce A; Gürakan F
Pediatr Int; 1999 Dec; 41(6):662-5. PubMed ID: 10618887
[TBL] [Abstract][Full Text] [Related]
27. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
[TBL] [Abstract][Full Text] [Related]
28. Clinical evidence of hepatoprotection induced by ursodeoxycholic acid.
Vincze A; Patty I; Jávor T; Pár A
Acta Physiol Hung; 1992; 80(1-4):369-74. PubMed ID: 1345203
[TBL] [Abstract][Full Text] [Related]
29. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Petersen C; Ballauff A; Brodehl J
Am J Gastroenterol; 2000 Dec; 95(12):3522-8. PubMed ID: 11151888
[TBL] [Abstract][Full Text] [Related]
30. [Progressive familial intrahepatic cholestasis presenting as liver failure].
Sangorrin Iranzo A; Iriondo Sanz M; Alvarez García L; Jara Vega P; Martín de Carpi J
An Pediatr (Barc); 2009 Dec; 71(6):510-3. PubMed ID: 19811957
[TBL] [Abstract][Full Text] [Related]
31. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
[TBL] [Abstract][Full Text] [Related]
32. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
33. Progressive familial intrahepatic cholestasis in Malaysian patients--a report of five cases.
Lee WS; Chai PF; Looi LM
Med J Malaysia; 2009 Sep; 64(3):216-9. PubMed ID: 20527271
[TBL] [Abstract][Full Text] [Related]
34. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
36. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
[TBL] [Abstract][Full Text] [Related]
37. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
38. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.
Yang H; Porte RJ; Verkade HJ; De Langen ZJ; Hulscher JB
J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):216-21. PubMed ID: 19561545
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic cholestasis of pregnancy: a case report.
Konjeti R; Selsky N
Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
[No Abstract] [Full Text] [Related]
40. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Grymowicz M; Czajkowski K; Smolarczyk R
Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
